EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-11.93%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$3.06B
AUM Growth
+$226M
(+8%)
Cap. Flow
+$578M
Cap. Flow
% of AUM
18.9%
Top 10 Holdings %
Top 10 Hldgs %
83.2%
Holding
374
New
73
Increased
133
Reduced
109
Closed
49
Top Buys
| 1 |
Alibaba
BABA
|
$315M |
| 2 |
Baidu
BIDU
|
$74M |
| 3 |
JD.com
JD
|
$72M |
| 4 |
NetEase
NTES
|
$47.9M |
| 5 |
Pinduoduo
PDD
|
$39.6M |
Top Sells
| 1 |
NIO
NIO
|
$10.7M |
| 2 |
KC
Kingsoft Cloud Holdings
KC
|
$9.2M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$7.55M |
| 4 |
Invesco QQQ Trust
QQQ
|
$7.48M |
| 5 |
United States Brent Oil Fund
BNO
|
$6.73M |
Sector Composition
| 1 | Consumer Discretionary | 63.45% |
| 2 | Communication Services | 21.89% |
| 3 | Technology | 6.77% |
| 4 | Healthcare | 2.13% |
| 5 | Financials | 1.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
301
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $186K | 0.01% |
+11,431
| New | +$186K |
|
|
MYOV
302
DELISTED
Myovant Sciences Ltd.
MYOV
| $181K | 0.01% |
+13,601
| New | +$181K |
|
303
Atara Biotherapeutics
ATRA
$90.7M
| $180K | 0.01% |
+777
| New | +$180K |
|
304
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $174K | 0.01% |
+13,486
| New | +$174K |
|
305
FibroGen
FGEN
$48.9M
| $167K | 0.01% |
+556
| New | +$167K |
|
|
DMTK
306
DELISTED
DermTech, Inc. Common Stock
DMTK
| $164K | 0.01% |
+11,153
| New | +$164K |
|
307
Alector
ALEC
$305M
| $163K | 0.01% |
+11,434
| New | +$163K |
|
308
MannKind Corp
MNKD
$1.7B
| $160K | 0.01% |
43,489
+17,038
| +64% | +$62.7K |
|
|
AGEN
309
Agenus
AGEN
$138M
| $144K | ﹤0.01% |
2,984
+254
| +9% | +$12.3K |
|
310
Viatris
VTRS
$12.2B
| $142K | ﹤0.01% |
13,088
+734
| +6% | +$7.96K |
|
311
Sangamo Therapeutics
SGMO
$165M
| $134K | ﹤0.01% |
23,101
+11,383
| +97% | +$66K |
|
312
ImmunityBio
IBRX
$2.27B
| $128K | ﹤0.01% |
22,816
+7,933
| +53% | +$44.5K |
|
|
RDUS
313
DELISTED
Radius Health, Inc.
RDUS
| $112K | ﹤0.01% |
12,738
+1,981
| +18% | +$17.4K |
|
314
Seres Therapeutics
MCRB
$169M
| $106K | ﹤0.01% |
744
+207
| +39% | +$29.5K |
|
|
GTHX
315
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $98K | ﹤0.01% |
12,869
+1,542
| +14% | +$11.7K |
|
316
Catalyst Pharmaceutical
CPRX
$2.48B
| $96K | ﹤0.01% |
+11,614
| New | +$96K |
|
317
MacroGenics
MGNX
$126M
| $92K | ﹤0.01% |
+10,417
| New | +$92K |
|
318
Organogenesis Holdings
ORGO
$634M
| $90K | ﹤0.01% |
11,780
-769
| -6% | -$5.88K |
|
|
VBIV
319
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $88K | ﹤0.01% |
1,772
+878
| +98% | +$43.6K |
|
|
ADAG
320
Adagene
ADAG
$104M
| $69K | ﹤0.01% |
19,310
-34,775
| -64% | -$124K |
|
|
CMRX
321
DELISTED
Chimerix, Inc.
CMRX
| $59K | ﹤0.01% |
+12,868
| New | +$59K |
|
322
Rigel Pharmaceuticals
RIGL
$742M
| $52K | ﹤0.01% |
1,747
+140
| +9% | +$4.17K |
|
323
MiMedx Group
MDXG
$1.06B
| $50K | ﹤0.01% |
+10,673
| New | +$50K |
|
324
Geron
GERN
$893M
| $43K | ﹤0.01% |
31,687
+12,869
| +68% | +$17.5K |
|
325
Akebia Therapeutics
AKBA
$785M
| $25K | ﹤0.01% |
35,250
+10,853
| +44% | +$7.7K |
|